VMT-𝛼-GEN: Elegantly Designed Pb-212 Isotope Generator

Enables a nimble supply of therapeutic radioisotope with the power of alpha-particle therapy for cancer

Harnessing the Power of Alpha-Particles

We have developed a proprietary isotope generator, VMT-𝛼-GEN, to deliver our therapeutic isotope Pb-212 for supply to patients. With a half-life of 10.6 hours, Pb-212 is ideally suited to deliver powerful alpha-particle therapy to cancerous tumors, while representing a lower risk for off-target unintended effects and the potential for treatment on an outpatient basis.

  • Abundant feedstock from nuclear and mining waste material
  • On demand daily doses
    • Auto-regenerates overnight
    • ≃1 week shelf life
  • Small footprint allows for benchtop use and simple logistics – the size of a coffee thermos
  • Long-term supply contract with the National Isotope Development Center of the U.S. Department of Energy Isotope Program
VMT-a-GEN: Isotope Generator

Want to know more about this new class of Theranostics?